Clinical trial

Microbicide Safety and Acceptability in Young Men

NCT01283360

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE1

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2015-05-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

High Risk MSMunresolved

HIV Negativeunresolved

18-30 Years of Ageunresolved

Interventions

HEC Placebo GelOTHER

Tenofovir 1% GelDRUG

Sponsors & collaborators

CONRADlead sponsor

National Institutes of Health (NIH)collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

National Institute of Mental Health (NIMH)collaborator

Mapped research locations

BostonMassachusetts, United States1 PittsburghPennsylvania, United States1 San JuanPuerto Rico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01283360 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.